Central Nervous System Depressants
"Central Nervous System Depressants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents).
| Descriptor ID |
D002492
|
| MeSH Number(s) |
D27.505.696.277 D27.505.954.427.210
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Depressants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Depressants".
This graph shows the total number of publications written about "Central Nervous System Depressants" by people in this website by year, and whether "Central Nervous System Depressants" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 0 | 3 |
| 1997 | 2 | 0 | 2 |
| 1998 | 3 | 3 | 6 |
| 1999 | 7 | 2 | 9 |
| 2000 | 7 | 5 | 12 |
| 2001 | 11 | 0 | 11 |
| 2002 | 5 | 2 | 7 |
| 2003 | 2 | 2 | 4 |
| 2004 | 5 | 2 | 7 |
| 2005 | 6 | 0 | 6 |
| 2006 | 9 | 6 | 15 |
| 2007 | 9 | 3 | 12 |
| 2008 | 9 | 7 | 16 |
| 2009 | 16 | 9 | 25 |
| 2010 | 8 | 7 | 15 |
| 2011 | 14 | 6 | 20 |
| 2012 | 9 | 4 | 13 |
| 2013 | 5 | 5 | 10 |
| 2014 | 6 | 5 | 11 |
| 2015 | 10 | 4 | 14 |
| 2016 | 6 | 5 | 11 |
| 2017 | 6 | 5 | 11 |
| 2018 | 5 | 5 | 10 |
| 2019 | 11 | 4 | 15 |
| 2020 | 8 | 3 | 11 |
| 2021 | 2 | 3 | 5 |
Below are the most recent publications written about "Central Nervous System Depressants" by people in Profiles.
-
Identification of Dihydromyricetin and Metabolites in Serum and Brain Associated with Acute Anti-Ethanol Intoxicating Effects in Mice. Int J Mol Sci. 2021 Jul 12; 22(14).
-
Ethanol's disruptive effects upon early breathing plasticity and blood parameters associated with hypoxia and hypercapnia. Exp Neurol. 2021 10; 344:113796.
-
Successful implementation of managed alcohol programs in the San Francisco Bay Area during the COVID-19 crisis. Subst Abus. 2021; 42(2):140-147.
-
The contribution of medium spiny neuron subtypes in the nucleus accumbens core to compulsive-like ethanol drinking. Neuropharmacology. 2021 04 01; 187:108497.
-
Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events. JAMA Netw Open. 2021 02 01; 4(2):e210061.
-
Early ethanol pre-exposure alters breathing patterns by disruptions in the central respiratory network and serotonergic balance in neonate rats. Behav Brain Res. 2021 01 01; 396:112908.
-
Melatonin treatment of repetitive behavioral deficits in the Cntnap2 mouse model of autism spectrum disorder. Neurobiol Dis. 2020 11; 145:105064.
-
Melatonin for Acute Treatment of Migraine in Children and Adolescents: A Pilot Randomized Trial. Headache. 2020 Sep; 60(8):1712-1721.
-
Inbred Substrain Differences Influence Neuroimmune Response and Drinking Behavior. Alcohol Clin Exp Res. 2020 09; 44(9):1760-1768.
-
Deficiency of Intestinal α1-2-Fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. Alcohol Clin Exp Res. 2020 09; 44(9):1842-1851.